Abstract

Amyloid-beta peptide (Aβ) and Tau protein are the lead constituents in the pathogenesis of Alzheimer's disease (AD). However, their inter-relationship in the disease process remains to be established. Tauopathy refers to a characteristic neurodegenerative process in AD. In tauopathy, Tau accumulates as a consequence of altered pre-mRNA splicing of tau exon 10, resulting in 3R (without exon 10)/4R (with exon 10) imbalance. We studied Aβ effects on tau exon 10 pre-mRNA splicing and relevant signaling events. This is the first demonstration of Aβ alteration of tau exon 10 splicing with an increase in 3R/4R ratio caused by reduced 4R expression. This Aβ βaction is causally related to its activation of GSK-3β which in turn phosphorylates SC35, an enhancer in tau exon 10 splicing. The establishment of the Aβ-GSK-3β-SC35 cascade broadens insight into development of novel strategies to modulate Aβ action on tau exon 10 splicing for possible prevention of tauopathy.

Original languageEnglish
Pages (from-to)378-385
Number of pages8
JournalNeurobiology of Disease
Volume40
Issue number2
DOIs
Publication statusPublished - Nov 2010

Fingerprint

Amyloid
Exons
Tauopathies
Peptides
Glycogen Synthase Kinase 3
RNA Precursors
Alzheimer Disease
tau Proteins
Amyloid beta-Peptides

Keywords

  • Alzheimer's disease
  • Corticobasal degeneration
  • Fronto-temporal dementia
  • GSK3β
  • Progressive supranuclear palsy
  • SC35
  • SH-SY5Y
  • Tau exon 10 splicing
  • Tauopathy

ASJC Scopus subject areas

  • Neurology

Cite this

Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway. / Chen, Kun Lin; Yuan, Rey Yue; Hu, Chaur Jong; Hsu, Chung-Yi.

In: Neurobiology of Disease, Vol. 40, No. 2, 11.2010, p. 378-385.

Research output: Contribution to journalArticle

@article{45522203927444caa6f52a512534fc91,
title = "Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway",
abstract = "Amyloid-beta peptide (Aβ) and Tau protein are the lead constituents in the pathogenesis of Alzheimer's disease (AD). However, their inter-relationship in the disease process remains to be established. Tauopathy refers to a characteristic neurodegenerative process in AD. In tauopathy, Tau accumulates as a consequence of altered pre-mRNA splicing of tau exon 10, resulting in 3R (without exon 10)/4R (with exon 10) imbalance. We studied Aβ effects on tau exon 10 pre-mRNA splicing and relevant signaling events. This is the first demonstration of Aβ alteration of tau exon 10 splicing with an increase in 3R/4R ratio caused by reduced 4R expression. This Aβ βaction is causally related to its activation of GSK-3β which in turn phosphorylates SC35, an enhancer in tau exon 10 splicing. The establishment of the Aβ-GSK-3β-SC35 cascade broadens insight into development of novel strategies to modulate Aβ action on tau exon 10 splicing for possible prevention of tauopathy.",
keywords = "Aβ, Alzheimer's disease, Corticobasal degeneration, Fronto-temporal dementia, GSK3β, Progressive supranuclear palsy, SC35, SH-SY5Y, Tau exon 10 splicing, Tauopathy",
author = "Chen, {Kun Lin} and Yuan, {Rey Yue} and Hu, {Chaur Jong} and Chung-Yi Hsu",
year = "2010",
month = "11",
doi = "10.1016/j.nbd.2010.06.013",
language = "English",
volume = "40",
pages = "378--385",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway

AU - Chen, Kun Lin

AU - Yuan, Rey Yue

AU - Hu, Chaur Jong

AU - Hsu, Chung-Yi

PY - 2010/11

Y1 - 2010/11

N2 - Amyloid-beta peptide (Aβ) and Tau protein are the lead constituents in the pathogenesis of Alzheimer's disease (AD). However, their inter-relationship in the disease process remains to be established. Tauopathy refers to a characteristic neurodegenerative process in AD. In tauopathy, Tau accumulates as a consequence of altered pre-mRNA splicing of tau exon 10, resulting in 3R (without exon 10)/4R (with exon 10) imbalance. We studied Aβ effects on tau exon 10 pre-mRNA splicing and relevant signaling events. This is the first demonstration of Aβ alteration of tau exon 10 splicing with an increase in 3R/4R ratio caused by reduced 4R expression. This Aβ βaction is causally related to its activation of GSK-3β which in turn phosphorylates SC35, an enhancer in tau exon 10 splicing. The establishment of the Aβ-GSK-3β-SC35 cascade broadens insight into development of novel strategies to modulate Aβ action on tau exon 10 splicing for possible prevention of tauopathy.

AB - Amyloid-beta peptide (Aβ) and Tau protein are the lead constituents in the pathogenesis of Alzheimer's disease (AD). However, their inter-relationship in the disease process remains to be established. Tauopathy refers to a characteristic neurodegenerative process in AD. In tauopathy, Tau accumulates as a consequence of altered pre-mRNA splicing of tau exon 10, resulting in 3R (without exon 10)/4R (with exon 10) imbalance. We studied Aβ effects on tau exon 10 pre-mRNA splicing and relevant signaling events. This is the first demonstration of Aβ alteration of tau exon 10 splicing with an increase in 3R/4R ratio caused by reduced 4R expression. This Aβ βaction is causally related to its activation of GSK-3β which in turn phosphorylates SC35, an enhancer in tau exon 10 splicing. The establishment of the Aβ-GSK-3β-SC35 cascade broadens insight into development of novel strategies to modulate Aβ action on tau exon 10 splicing for possible prevention of tauopathy.

KW - Aβ

KW - Alzheimer's disease

KW - Corticobasal degeneration

KW - Fronto-temporal dementia

KW - GSK3β

KW - Progressive supranuclear palsy

KW - SC35

KW - SH-SY5Y

KW - Tau exon 10 splicing

KW - Tauopathy

UR - http://www.scopus.com/inward/record.url?scp=79952694499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952694499&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2010.06.013

DO - 10.1016/j.nbd.2010.06.013

M3 - Article

VL - 40

SP - 378

EP - 385

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 2

ER -